Zymeworks
ZYME
120 hedge funds and large institutions have $327M invested in Zymeworks in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 19 reducing their positions, and 23 closing their positions.
174% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 19
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
5% more funds holding
Funds holding: 114 → 120 (+6)
4% more call options, than puts
Call options by funds: $846K | Put options by funds: $816K
4.41% less ownership
Funds ownership: 90.95% → 86.54% (-4.4%)
53% less capital invested
Capital invested by funds: $694M → $327M (-$367M)
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$40.2M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$22.8M |
| 3 |
PA
Perceptive Advisors
New York
|
+$14.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$11M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$23.7M |
| 4 |
Goldman Sachs
New York
|
-$17.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$15M |
ZYME Hedge Fund Activity: Q1 2022 in Review
120 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2022, worth a combined $327M — down 53% from $694M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ZYME positions and 23 closed out — a net gain of 6 holders — while 52 added to existing stakes and 19 trimmed.
The largest buyer was Armistice Capital, adding an estimated $40.2M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $28.1M sold.
- 120 institutional investors held Zymeworks (ZYME) as of Q1 2022, up from 114 in Q4 2021.
- Funds reported $327M of Zymeworks stock for Q1 2022, down 53% quarter-over-quarter.
- 29 funds opened new Zymeworks positions in Q1 2022 and 23 closed out, a net change of +6 holders.
- The largest Zymeworks buyer in Q1 2022 was Armistice Capital, an estimated $40.2M added.
- The largest Zymeworks seller in Q1 2022 was T. Rowe Price Associates, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2022.